Venture Life Group (LON:VLG – Get Free Report) released its quarterly earnings results on Tuesday. The company reported GBX 4.10 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Venture Life Group had a return on equity of 7.82% and a net margin of 17.42%.
Venture Life Group Trading Down 4.7%
Shares of Venture Life Group stock opened at GBX 65 on Wednesday. The firm has a 50-day moving average of GBX 67.48 and a 200-day moving average of GBX 65.11. The stock has a market cap of £78.03 million, a PE ratio of 14.87, a PEG ratio of 5.67 and a beta of 0.23. Venture Life Group has a 52-week low of GBX 52 and a 52-week high of GBX 72. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.48 and a current ratio of 4.71.
Venture Life Group Company Profile
Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.
Featured Articles
- Five stocks we like better than Venture Life Group
- CarMax Just Gave Investors a Better Reason to Believe in the Turnaround
- CoreWeave Comes With Risks: Analysts Split on What Matters Most
- Bottlenecking the Future: TSMC Prices Out the Competition
- Fervo Energy Hits Geothermal Milestone: Will It Matter For The Stock?
Receive News & Ratings for Venture Life Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venture Life Group and related companies with MarketBeat.com's FREE daily email newsletter.
